Abstract: The present invention relates to the process for preparation, isolation and purification of Cilastatin acid of formula -I or its pharmaceutically accepted salt by treating 7-chloro-2-[[(1S)-2,2'-di-methylcyclopropane] carboxamide]-2-heptanoic acid of formula-Ill with L-cysteine hydrochloride in presence of base in alcoholic solvent to obtain Cilastatin acid of compound formula-I. Further the obtained formula-I treated with sodium source in alcoholic solvent to obtained sodium salt of formula-I. The present invention further relates to the process for preparation of Cilastatin acid intermediate of formula-VI.
| # | Name | Date |
|---|---|---|
| 1 | 201621007813-Other Patent Document-070316.pdf | 2018-08-11 |
| 2 | 201621007813-Form 5-070316.pdf | 2018-08-11 |
| 3 | 201621007813-Form 3-070316.pdf | 2018-08-11 |
| 4 | 201621007813-Form 2(Title Page)-070316.pdf | 2018-08-11 |
| 5 | 201621007813-Form 1-070316.pdf | 2018-08-11 |